World's Best Scientists 2026 revealed!
Christopher P. Leamon

Christopher P. Leamon

Christopher P. Leamon publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Christopher P. Leamon sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

The last bar groups every scientist with 1,295 publications or more.

Christopher P. Leamon D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher P. Leamon sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

The last bar groups every scientist with 159 D-Index or more.

Overview

Christopher P. Leamon is affiliated with Fusion Pharmaceuticals in the United States. Their research primarily spans the medical field with a focus on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology, and Public Health, Environmental and Occupational Health.

The scientist's work covers various topics including:

  • Radiopharmaceutical Chemistry and Applications
  • Autoimmune and Inflammatory Disorders Research
  • Immune Cell Function and Interaction
  • Acute Lymphoblastic Leukemia research
  • Genomic variations and chromosomal abnormalities
  • Cancer-related Molecular Pathways
  • DNA and Nucleic Acid Chemistry

Christopher P. Leamon has contributed to several publications over recent years. Notable papers include:

  • Targeting folate receptor beta on monocytes/macrophages renders rapid inflammation resolution independent of root causes, 2021, Cell Reports Medicine
  • Pre-clinical studies of EC2629, a highly potent folate-receptor-targeted DNA crosslinking agent, 2020, Scientific Reports
  • Design and synthesis of a folate-receptor targeted diazepine-ring-opened pyrrolobenzodiazepine prodrug conjugate, 2020, Bioorganic & Medicinal Chemistry Letters
  • A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats, 2021, Cells
  • Abstract 5045: NTSR1-targeted alpha therapeutic [Ac-225]-FPI-2059 induces growth inhibition in a preclinical colorectal tumor model, 2023, Cancer Research

Frequent co-authors include:

  • John F. Valliant (4 publications)
  • Iontcho R. Vlahov (3 publications)
  • Brigitte L. Thériault (3 publications)
  • Yingjuan Lu (2 publications)
  • Paul J. Kleindl (2 publications)

Their research has appeared predominantly in the following journals:

  • Cancer Research (4 publications)
  • Cell Reports Medicine (1 publication)
  • Scientific Reports (1 publication)
  • Bioorganic & Medicinal Chemistry Letters (1 publication)
  • Cells (1 publication)

Best Publications

  • Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.

    Christopher P. Leamon;Philip S. Low

  • Folate-targeted chemotherapy

    Christopher P Leamon;Joseph A Reddy

  • Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.

    Christopher P Leamon;Matthew A Parker;Iontcho R Vlahov;Le-Cun Xu

  • Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery

    Chrystal M. Paulos;Joseph A. Reddy;Christopher P. Leamon;Mary Jo Turk

  • Engineering folate-drug conjugates to target cancer: from chemistry to clinic.

    Iontcho R. Vlahov;Christopher P. Leamon

  • Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.

    Christopher P Leamon;Scott R Cooper;Gregory E Hardee

  • Endocytosis of folate-protein conjugates: Ultrastructural localization in KB cells

    John J. Turek;Christopher P. Leamon;Philip S. Low

  • Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain.

    Christopher P. Leamon;Ira Pastan;Philip Low

  • Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors.

    J A Reddy;C Abburi;H Hofland;S J Howard

  • Cytotoxicity of momordin-folate conjugates in cultured human cells.

    C. P. Leamon;Philip Low

  • Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells

    C P Leamon;P S Low

  • Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide

    Iontcho R. Vlahov;Hari Krishna R. Santhapuram;Paul J. Kleindl;Stephen J. Howard

  • Preclinical Evaluation of 99mTc-EC20 for Imaging Folate Receptor–Positive Tumors

    Joseph A. Reddy;Le-Cun Xu;Nikki Parker;Marilynn Vetzel

  • Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic.

    Christopher P. Leamon;Joseph A. Reddy;Iontcho R. Vlahov;Marilynn Vetzel

  • Method for tumor imaging and composition

    Philip Stewart Low;ロウ,フィリップ,スチュワート;Mark A Green;グリーン,マーク,エー.

  • Folate mimetics and folate-receptor binding conjugates thereof

    Mark A. Green;Chun-Yen Ke;Christopher P. Leamon

  • Vitamin receptor binding drug delivery conjugates

    Iontcho Radoslavov Vlahov;Christopher Paul Leamon;Matthew A. Parker;Stephen J. Howard

  • Comparative preclinical activity of the folate-targeted Vinca alkaloid conjugates EC140 and EC145.

    Christopher P. Leamon;Joseph A. Reddy;Iontcho R. Vlahov;Elaine Westrick

  • Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.

    Joseph A. Reddy;Elaine Westrick;Iontcho Vlahov;Stephen J. Howard

  • Fusogenic lipids and vesicles

    Christopher Paul Leamon

Frequent Co-Authors

Philip S. Low
Philip S. Low Purdue University West Lafayette
Haiyan Chu
Haiyan Chu Endocyte (United States)
Roger Schibli
Roger Schibli ETH Zurich
Kevin K. W. Wang
Kevin K. W. Wang Morehouse School of Medicine
Larry H. Matherly
Larry H. Matherly Wayne State University
Robert J. Lee
Robert J. Lee University of Pennsylvania
Emmett V. Schmidt
Emmett V. Schmidt MSD (United States)
Francois Villinger
Francois Villinger University of Louisiana at Lafayette
Yehuda G. Assaraf
Yehuda G. Assaraf Technion – Israel Institute of Technology
Gerrit Jansen
Gerrit Jansen Amsterdam UMC

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors not only to traditional scientific roles but also to interdisciplinary fields like forensic science. For those interested in applying chemical principles to legal investigations, exploring a forensic science career can be a rewarding option. This pathway blends chemistry with criminal justice, demanding specialized knowledge and analytical skills.

To enter related fields, many students consider online degree programs for flexibility and affordability. Understanding the criminal justice degree online cost is essential for budgeting and planning, as tuition can vary widely between institutions.

For those seeking an accessible starting point, the best online criminal justice associate degree programs provide foundational knowledge and practical skills relevant to law enforcement, legal studies, and regulatory roles. These programs can also serve as a stepping stone toward more advanced degrees.

Additionally, chemistry students interested in the legal system might explore opportunities as a paralegal. Pursuing a paralegal associate degree offers a pathway into legal support roles, combining organizational skills with an understanding of scientific evidence and documentation. This diverse range of online degrees makes career transitions and interdisciplinary specialization more accessible than ever.

Best Scientists Citing Christopher P. Leamon

Trending Scientists

Recently Published Articles